Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ronghai Bo"'
Autor:
Alexander Liede, Rohini K. Hernandez, Sally W. Wade, Ronghai Bo, Nathan C. Nussbaum, Elizabeth Ahern, William C. Dougall, Mark J. Smyth
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
After a case report of profound clinical response in a melanoma patient following treatment with an immune checkpoint inhibitor (ICI) and RANK-ligand inhibitor denosumab, we identified similar patients from electronic health records (EHR) and describ
Externí odkaz:
https://doaj.org/article/b10ac2dd6b934fe491245e01e9a27a05
Autor:
Nadera J Sweiss, Ronghai Bo, Reena Kapadia, Deborah Manst, Farzan Mahmood, Tara Adhikari, Suncica Volkov, Maria Badaracco, Mary Smaron, Anthony Chang, Joseph Baron, Jerrold S Levine
Publikováno v:
PLoS ONE, Vol 5, Iss 8, p e12280 (2010)
BackgroundThe clinical utility of testing for antiphospholipid antibodies (aPL) of IgA isotype remains controversial.Methodology/principal findingsTo address this issue, we reasoned that if IgA aPL contribute to the clinical manifestations of the ant
Externí odkaz:
https://doaj.org/article/bcd6a91bee5d4518a6fbce993519e1b8
Autor:
Mark J. Smyth, Rohini K. Hernandez, Elizabeth Ahern, Alexander Liede, Sally W. Wade, Ronghai Bo, Nathan C. Nussbaum, William C. Dougall
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
After a case report of profound clinical response in a melanoma patient following treatment with an immune checkpoint inhibitor (ICI) and RANK-ligand inhibitor denosumab, we identified similar patients from electronic health records (EHR) and describ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::119b0ed260a20d7847909733609b71a4
https://europepmc.org/articles/PMC6279336/
https://europepmc.org/articles/PMC6279336/
Autor:
Ronghai Bo, Hilary Steltenpohl, Megan Zuelsdorff, Corinne D. Engelman, F. Javier Nieto, Taylor Kirby
Publikováno v:
Clinical Nutrition. 33:421-425
Summary Background & aims Vitamin D is associated with many health outcomes and the blood concentration of 25-hydroxyvitamin D [25(OH)D] is commonly measured in clinical practice. A C-3 epimer of this compound, 3-epi-25(OH)D 3 , has recently been det
Autor:
Sweiss, Nadera J., Ronghai Bo, Kapadia, Reena, Manst, Deborah, Mahmood, Farzan, Adhikari, Tara, Volkov, Suncica, Badaracco, Maria, Smaron, Mary, Chang, Anthony, Baron, Joseph, Levine, Jerrold S.
Publikováno v:
PLoS ONE. 2010, Vol. 5 Issue 8, p1-6. 6p. 3 Charts, 1 Graph.
Autor:
Rohini K. Hernandez, William C. Dougall, Mark J. Smyth, Sally W. Wade, Ronghai Bo, Elizabeth Ahern, Alexander Liede
Publikováno v:
Journal of Clinical Oncology. 36:e21001-e21001
e21001Background: After a case report of a melanoma (MEL) patient (pt) who had profound clinical response after treatment with an immune checkpoint inhibitor (ICI) and RANK-ligand inhibitor denosum...
Autor:
Jingrui Jiang, Edward A. Fox, Ellen Weisberg, Matthew Meyerson, Anna Jonasova, James D. Griffin, Brian M. Wolpin, Daniel J. DeAngelo, Ronghai Bo, Michael J. Eck, J. Guillermo Paez, Richard Stone, Ilene Galinsky, Paula Herman, Titus J. Boggon, Jeffrey C. Lee, William R. Sellers, D. Gary Gilliland
Publikováno v:
Blood. 104:1855-1858
The FLT3 receptor is activated by juxtamembrane insertion mutations and by activation loop point mutations in patients with acute myeloid leukemia (AML). In a systematic tyrosine kinase gene exon resequencing study, 21 of 24 FLT3 exons were sequenced
Autor:
Stephen Scaringe, Olivia Bare, Francisca Vazquez, Anastasia Khvorova, Ronghai Bo, Judith Manola, Andrew C. Hsieh, William R. Sellers
Publikováno v:
Nucleic Acids Research. 32:893-901
Gene silencing through RNA interference (RNAi) has been established as a means of conducting reverse genetic studies. In order to better understand the determinants of short interfering RNA (siRNA) knockdown for use in high-throughput cell-based scre
Autor:
Robert B. Stewart, Peter Castelluccio, Tatiana Foroud, Aimee Ritchotte, Paula J. Bice, Ting-Kai Li, Lucinda G. Carr, Ronghai Bo, L. Lumeng
Publikováno v:
Behavior Genetics. 32:57-67
The inbred preferring (iP) and nonpreferring (iNP) rat strains were derived from the selectively bred alcohol-preferring (P) and alcohol-nonpreferring (NP) lines. Previously, 381 iP × iNP F2 progeny were generated to identify quantitative trait loci
Autor:
Aimee Ritchotte, Ronghai Bo, Tatiana Foroud, Paula J. Bice, Peter Castelluccio, Lawrence Lumeng, Laurie Miller, Lucinda G. Carr, Ting-Kai Li
Publikováno v:
Behavior Genetics. 30:131-140
Selective breeding has been employed to develop high-alcohol-drinking (HAD) and low-alcohol-drinking (LAD) rat lines from the heterogeneous N/Nih rat. Within-family selection and a rotational breeding design were used to discourage inbreeding (Li et